Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zerong Cai

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Cell Death & Disease|January 30, 2026
Lactylation of SLC26A3 in the acidic tumor microenvironment promotes malignant progression of colorectal carcinomaChong Chen, Du Cai, Xuanhui Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 9, 2021
Inhibition of the PLK1-Coupled Cell Cycle Machinery Overcomes Resistance to Oxaliplatin in Colorectal CancerZhaoliang Yu, Peng Deng, Yufeng Chen, et al.
Nature Communications|June 2, 2026
Mevalonate pathway rewiring driven by enhancer remodelling confers resistance to KRAS inhibitors in colorectal cancerYaoyu Guo, Yi Zhong, Peishan Hu, et al.
International Journal of Surgery (London, England)|February 13, 2024
Evaluation of transrectal ultrasound-guided tru-cut biopsy as a complementary method for predicting pathological complete response in rectal cancer after neoadjuvant treatment: a phase II prospective and diagnostic trialYaoyi Huang, Yumo Xie, Puning Wang, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Cell Death & Disease|January 30, 2026
Lactylation of SLC26A3 in the acidic tumor microenvironment promotes malignant progression of colorectal carcinomaChong Chen, Du Cai, Xuanhui Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 9, 2021
Inhibition of the PLK1-Coupled Cell Cycle Machinery Overcomes Resistance to Oxaliplatin in Colorectal CancerZhaoliang Yu, Peng Deng, Yufeng Chen, et al.
Nature Communications|June 2, 2026
Mevalonate pathway rewiring driven by enhancer remodelling confers resistance to KRAS inhibitors in colorectal cancerYaoyu Guo, Yi Zhong, Peishan Hu, et al.
International Journal of Surgery (London, England)|February 13, 2024
Evaluation of transrectal ultrasound-guided tru-cut biopsy as a complementary method for predicting pathological complete response in rectal cancer after neoadjuvant treatment: a phase II prospective and diagnostic trialYaoyi Huang, Yumo Xie, Puning Wang, et al.
Pageof 4